Bruker (BKD) Financial Statements
Bruker Financial Overview
Bruker's market cap is currently $7.16B. The company's EPS TTM is $-0.70; its P/E ratio is -81.64; and it has a dividend yield of 0.34%. Bruker is estimated to report earnings on November 4, 2026, and the estimated EPS forecast is $0.35. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 3.44B | $ 3.37B | $ 2.96B | $ 2.53B | $ 2.42B |
| Gross Profit | $ 1.58B | $ 1.65B | $ 1.51B | $ 1.31B | $ 1.21B |
| Operating Income | $ 236.00M | $ 253.10M | $ 436.90M | $ 432.70M | $ 413.30M |
| EBITDA | $ 302.60M | $ 438.60M | $ 675.50M | $ 518.70M | $ 497.00M |
| Net Income | $ -8.60M | $ 113.10M | $ 427.20M | $ 296.60M | $ 277.10M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 298.80M | $ 183.40M | $ 488.30M | $ 645.50M | $ 1.17B |
| Total Assets | $ 6.24B | $ 5.81B | $ 4.25B | $ 3.61B | $ 3.65B |
| Total Debt | $ 2.04B | $ 2.25B | $ 1.38B | $ 1.27B | $ 1.39B |
| Net Debt | $ 1.74B | $ 2.06B | $ 891.30M | $ 624.90M | $ 325.70M |
| Total Liabilities | $ 3.73B | $ 3.99B | $ 2.84B | $ 2.48B | $ 2.57B |
| Stockholders' Equity | $ 2.46B | $ 1.78B | $ 1.38B | $ 1.11B | $ 1.07B |
| Cash Flow | |||||
| Free Cash Flow | $ 13.90M | $ 136.00M | $ 243.20M | $ 145.20M | $ 190.40M |
| Operating Cash Flow | $ 134.10M | $ 251.30M | $ 350.10M | $ 274.40M | $ 282.40M |
| Investing Cash Flow | $ -196.50M | $ -1.76B | $ -326.00M | $ -251.60M | $ -192.40M |
| Financing Cash Flow | $ 135.10M | $ 1.23B | $ -193.40M | $ -415.30M | $ 318.70M |
Currency in USD